Metalloproteinases: role in breast carcinogenesis, invasion and metastasis (Q24803225)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Metalloproteinases: role in breast carcinogenesis, invasion and metastasis	scientific article

Statements

scholarly article

0 references

1 reference

19 January 2021

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis (English)

0 references

1 reference

19 January 2021

breast neoplasm

1 reference

19 January 2021

metalloendopeptidase

1 reference

28 September 2019

neoplasm protein

1 reference

18 December 2019

neoplasm invasiveness

1 reference

19 January 2021

1 reference

based on heuristic

inferred from title

author name string

T M Maguire

2

0 references

A Hill

3

0 references

E McDermott

4

0 references

N O'Higgins

5

0 references

language of work or name

0 references

publication date

7 June 2000

6 references

13 March 2019

3 April 2019

17 June 2019

28 September 2019

18 December 2019

19 January 2021

Breast Cancer Research

6 references

13 March 2019

3 April 2019

17 June 2019

28 September 2019

18 December 2019

19 January 2021

2

0 references

4

0 references

252-7

0 references

Furin-dependent intracellular activation of the human stromelysin-3 zymogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

7 April 2017

Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

7 April 2017

Stromelysin-3 in the biology of the normal and neoplastic mammary gland.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins (review).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Clinical studies with matrix metalloproteinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Membrane-type matrix metalloproteinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

An odyssey from breast to bone: multi-step control of mammary metastases and osteolysis by matrix metalloproteinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Cancer invasion and tissue remodeling--cooperation of protease systems and cell types.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

The biochemistry of metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

The role of stromelysin-1 in stromal-epithelial interactions and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Activity of type IV collagenases in benign and malignant breast disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Do proteases play a role in cancer invasion and metastasis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 September 2017

Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

30 May 2018

Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

30 May 2018

Angiogenesis and tumor metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

30 May 2018

Changing views of the role of matrix metalloproteinases in metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

30 May 2018

The urokinase-type plasminogen activator system in cancer metastasis: A review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

30 May 2018

The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

30 May 2018

Type IV collagenase immunoreactivity in invasive breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

30 May 2018

Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.

1 reference

https://api.crossref.org/works/10.1186%2FBCR65

21 January 2018

High levels of TIMP-2 correlate with adverse prognosis in breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2FBCR65

21 January 2018

Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138784

28 November 2018

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An essential role for ectodomain shedding in mammalian development

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24803225&oldid=2175273834"